Consumer News Ftc Alleges Caremark Rx, Express Scripts, Optum Rx Inflated Insulin Prices
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Consumer News Ftc Alleges Caremark Rx, Express Scripts, Optum Rx Inflated Insulin Prices is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Eighth Circuit Hears Challenge to FTC Action Over Insulin Costs
Judges on a federal appeals court questioned pharmacy benefit managers Wednesday over the merits of their case against the Federal Trade Commission, which seeks to halt the agency’s internal ... Read More
O'Reilly lawsuit alleges prescription managers, manufacturers inflate insulin costs
O'Reilly Automotive Inc. is suing major pharmacy benefit managers (PBMs) and insulin manufacturers, alleging collusion to inflate insulin prices. The lawsuit accuses CVS Caremark, Express Scripts, ... Read More
Penn sues drug manufacturers, pharmacy intermediaries over alleged insulin price-fixing scheme
Penn filed a lawsuit on July 11 alleging that drug manufacturers and pharmacy benefit managers engaged in price fixing to artificially inflate the cost of treatments including insulin. Credit: Sydney ... Read More
University of Pennsylvania lawsuit alleges price-fixing by drugmakers and intermediaries have led to inflated insulin prices
From Philly and the Pa. suburbs to South Jersey and Delaware, what would you like WHYY News to cover? Let us know! A lawsuit filed in federal court on behalf of the University of Pennsylvania and its ... Read More
FTC finds middlemen inflate specialty generic drug prices by billions of dollars
(CNN) — Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic ... Read More
Federal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices
(CNN) — The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ... Read More
U. Penn. lawsuit alleges price-fixing by drugmakers and intermediaries have led to inflated insulin prices
A lawsuit filed in federal court on behalf of the University of Pennsylvania and its health system alleges that 20 years of skyrocketing prices on drugs that treat diabetes, like insulin, can be ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus